Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

UIC Center Funds 7 Projects with Potential for Human Therapies

04.03.2009
The University of Illinois at Chicago Center for Clinical and Translational Science has awarded $515,000 over two years to seven UIC research projects with great potential to move from laboratory to clinical investigation.

The center's pilot grant program looks for UIC projects that involve human subjects or facilitate human subject investigations and have clear, near-term implications for therapeutics or prevention.

The seven projects were chosen from 75 proposals submitted by investigators from 17 different departments and four colleges.

"The large number of meritorious applications for this grant cycle made the selection process tough," said center director Dr. Theodore Mazzone. "But it speaks well of the potential for UIC to continue to expand its footprint in clinical translational research."

The one- and two-year pilot grants will support early investigations vital to securing long-term funding for cutting-edge research. The program is funded by the UIC Office of the Provost, the Office of the Vice Chancellor for Research, and UIC's six health science colleges.

One pilot grant will develop a collaborative research program in asthma and allergic diseases. Steven J. Ackerman, professor of biochemistry and molecular genetics, will act as principal investigator on the project,

"Mast Cell, Macrophage, and Eosinophil Interactions in Asthma," with co-investigators Dr. John Christman, professor of pulmonary, critical care and sleep medicine; Richard Ye, professor of pharmacology, and H. Ari Jaffe, associate professor of pulmonary, critical care and sleep medicine.

A simple case of the flu can pose a deadly threat to people whose immune system is suppressed to prevent rejection of a transplanted organ. One pilot grant will explore a promising immunotherapy to treat severe infections in patients with compromised immune systems. Marlene Bouvier, associate professor of microbiology and immunology, will act as principal investigator on the project, "T-cell Immunotherapy for Adenoviral Infections of Hematopoietic Stem Cell Transplant Patients," with co-investigator Dr. James Cook, professor of infectious diseases.

Studies of human cancers begin in tissue culture, but often cells grown in a Petri dish won't continue to behave and respond like a natural cell in the body. As a result, it becomes almost impossible to learn how these cells become cancerous. One pilot grant will obtain a type of ovarian cell that is the progenitor of 90 percent of all ovarian cancers and develop a three-dimensional system that allows the cells to live and grow normally. Joanna E. Burdette, assistant professor of medicinal chemistry and pharmacognosy, will act as principal investigator with co-investigator Dr. Nita Lee, assistant professor in obstetrics and gynecology.

A project bringing together research expertise from three UIC medical campuses -- Chicago, Urbana-Champaign and Rockford -- will focus on a multi-disciplinary approach to improving cancer care for rural residents. Michael Glasser, associate dean for rural health professions at the UIC College of Medicine at Rockford, will act as principal investigator while Usha Menon, associate professor of biobehavioral health science in the College of Nursing and Lissette Piedra, assistant professor of social work at Urbana-Champaign are co-investigators.

A pilot grant that will produce the first human data from the multi-electrode electroretinogram will show this promising diagnostic tool's potential for mapping retinal health. Ophthalmologists hope that meERG will aid in early detection of a number of blinding diseases, including retinitis pigmentosa, age-related macular degeneration, and diabetic retinopathy. John Hetling, associate professor of bioengineering, is principal investigator on the grant, "Novel Electroretinographic Mapping of Retinal Function for Diagnosis of Progressive Eye Disease," and co-investigator is Janet Szlyk, professor of ophthalmology and visual sciences.

Beta-blockers are the major therapy used to treat ischemic heart diseases, which affect an estimated 14 million Americans. But a quarter of patients can't tolerate beta-blockers -- asthma patients, for example, can suffer life-threatening airway constriction. One pilot grant will explore alternative drug candidates in animal and human tissue systems based on previous study of signaling pathways in cardiac cells. Yunbo Ke, research assistant professor of physiology and biophysics, and R. John Solaro, professor physiology and biophysics will act as co-principal investigators on the grant, "Activation of P21 Activated Kinase-1 as a Novel Therapeutic Strategy for Ischemic Heart Diseases" with Dr. Samuel C. Dudley, professor of cardiology, as co-investigator.

Malignant gliomas are among the most lethal brain tumors, with a high rate of recurrence despite surgery, radiation and chemotherapy. Tumor cells are believed to hide out in areas of the brain called white-matter fiber tracts, allowing the tumor to regrow following treatment. Xiaohong Joe Zhou, associate professor of neurological surgery, will act as principal investigator in a project to determine whether a specialized magnetic resonance imaging technique can identify white-matter fiber tracts that have been invaded by tumor cells. His co-investigators on the project, "A Pilot Study of White Matter Involvement in Glioma Patients Using High-Resolution Diffusion MRI," are Dr. Herbert H. Engelhard, associate professor of neurological surgery; Dr. John L. Villano, assistant professor of oncology; and Dr. Tibor Valyi-Nagy, associate professor of pathology.

Jeanne Galatzer-Levy | Newswise Science News
Further information:
http://www.uic.edu

More articles from Science Education:

nachricht Studying outdoors is better
06.02.2018 | Technische Universität München

nachricht Classroom in Stuttgart with Li-Fi of Fraunhofer HHI opened
03.11.2017 | Fraunhofer-Institut für Nachrichtentechnik, Heinrich-Hertz-Institut, HHI

All articles from Science Education >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: In best circles: First integrated circuit from self-assembled polymer

For the first time, a team of researchers at the Max-Planck Institute (MPI) for Polymer Research in Mainz, Germany, has succeeded in making an integrated circuit (IC) from just a monolayer of a semiconducting polymer via a bottom-up, self-assembly approach.

In the self-assembly process, the semiconducting polymer arranges itself into an ordered monolayer in a transistor. The transistors are binary switches used...

Im Focus: Demonstration of a single molecule piezoelectric effect

Breakthrough provides a new concept of the design of molecular motors, sensors and electricity generators at nanoscale

Researchers from the Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague), Institute of Physics of the CAS (IP CAS) and Palacký University...

Im Focus: Hybrid optics bring color imaging using ultrathin metalenses into focus

For photographers and scientists, lenses are lifesavers. They reflect and refract light, making possible the imaging systems that drive discovery through the microscope and preserve history through cameras.

But today's glass-based lenses are bulky and resist miniaturization. Next-generation technologies, such as ultrathin cameras or tiny microscopes, require...

Im Focus: Stem cell divisions in the adult brain seen for the first time

Scientists from the University of Zurich have succeeded for the first time in tracking individual stem cells and their neuronal progeny over months within the intact adult brain. This study sheds light on how new neurons are produced throughout life.

The generation of new nerve cells was once thought to taper off at the end of embryonic development. However, recent research has shown that the adult brain...

Im Focus: Interference as a new method for cooling quantum devices

Theoretical physicists propose to use negative interference to control heat flow in quantum devices. Study published in Physical Review Letters

Quantum computer parts are sensitive and need to be cooled to very low temperatures. Their tiny size makes them particularly susceptible to a temperature...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

2nd International Conference on High Temperature Shape Memory Alloys (HTSMAs)

15.02.2018 | Event News

Aachen DC Grid Summit 2018

13.02.2018 | Event News

How Global Climate Policy Can Learn from the Energy Transition

12.02.2018 | Event News

 
Latest News

Researchers invent tiny, light-powered wires to modulate brain's electrical signals

21.02.2018 | Life Sciences

The “Holy Grail” of peptide chemistry: Making peptide active agents available orally

21.02.2018 | Life Sciences

Atomic structure of ultrasound material not what anyone expected

21.02.2018 | Materials Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>